News Quantified

HROW – harrow, inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Harrow’s ImprimisRx Subsidiary Receives $34.9 Million Unanimous Jury Verdict Award in ImprimisRx, LLC v. OSRX, Inc.

Melt Pharmaceuticals Reports Positive Phase 3 Topline Efficacy Results for MELT-300, Its Lead Product Candidate for Opioid-Free, Sublingual Procedural Sedation in Patients Undergoing Cataract Surgery

Harrow Announces Participation in Upcoming Investor Conferences

Harrow Announces Third Quarter 2024 Financial Results

Harrow Launches Access and Affordability Program with Price Reductions for Branded Products

-19.1%

MISS

54.3%

BEAT

34.5%

MISS

Form 10-Q HARROW, INC. For: Sep 30

Form 8-K HARROW, INC. For: Nov 13

Form 8-K HARROW, INC. For: Oct 25

Form SC 13G/A HARROW, INC. Filed by: Ophir Asset Management Pty Ltd

Form 4 HARROW, INC. For: Sep 11 Filed by: SAHAREK JOHN P.

Top News Gainers

11/13 Q3/2019 9/30/2019 EPS -0.450 ZacksConsensus -0.020 ActVsEst (0.430) - Miss 23.5%

3/13 Harrow Health Publishes Fourth Quarter 2019 Letter to Stockholders 17.2%

3/24 ImprimisRx® Announces Exclusive Agreement with Doxy.me to Provide Healthcare Professionals with Telemedicine Services 9.7%

8/15 SHAREHOLDER ALERT: Investigation of Harrow Health Announced by Holzer & Holzer, LLC 8.8%

5/9 Harrow Health Announces First Quarter 2019 Financial Results 8.2%

5/15 Harrow Health (NASDAQ: HROW) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 7.9%

9/5 Form 8-K HARROW HEALTH, INC. For: Sep 05 7.1%

5/12 Harrow Health, Inc. (HROW) CEO Mark Baum on Q1 2019 Results - Earnings Call Transcript [Seeking Alpha] 5.2%

6/25 Harrow Health Adds Two Senior Executives to its Nashville Team 5.2%

3/3 ImprimisRx® Announces Supply Agreement with Vision Center Network of America (VCNA) 4.1%

Top News Decliners

8/14 Form 4 HARROW HEALTH, INC. For: Aug 12 Filed by: Kammer Robert J -24.8%

3/16 Harrow Health (NASDAQ: HROW) had its price target lowered by analysts at B. Riley from $12.75 to $12.00. They now have a "buy" rating on the stock. -24.3%

3/12 ImprimisRx® Announces Supply Agreement with EyeCare Services Partners -15.0%

5/17 Form 8-K HARROW HEALTH, INC. For: May 16 -9.3%

6/28 Form 4 HARROW HEALTH, INC. For: Jun 26 Filed by: AUSTIN STEPHEN G -8.6%

8/30 Form 8-K HARROW HEALTH, INC. For: Aug 27 -7.5%

12/11 Form 8-K HARROW HEALTH, INC. For: Dec 11 -5.7%

12/4 Harrow Health (NASDAQ: HROW) was upgraded by analysts at ValuEngine from a "sell" rating to a "hold" rating. -5.2%

4/24 Form DEF 14A HARROW HEALTH, INC. For: Apr 24 -4.8%

3/9 ImprimisRx® Announces Supply Agreement with iOR Partners -4.7%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day